Studies

  1. Ustekinumab in CD. Treat to target or standard of care

  2. Adalimumab eow vs ew in UC

  3. Adalimumab eow vs ew in CD

  4. Infliximab IV to SC in IBD

  5. AntiTNF impact on IBD surgery

  6. Self-expandable metal stents vs endoscopic balloon dilation for the treatment of strictures in Crohn’s disease

  7. AntiTNF and surgery in perianal CD

  8. Steroid exposure and perinatal outcomes

  9. Mirikizumab phase 2 in CD

  10. Lyophilised oral microbiota transplantation for UC